Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02410837 · ClinicalTrials.gov registry record

NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™

A clinical trial, sponsored by Medtronic - MITG.

Completed
Registry status
1,388
Enrollment target

NCT02410837 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 1,388 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02410837 has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
1,388 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate outcomes following electromagnetic navigation bronchoscopy™ (ENB™) procedures using the superDimension™ navigation system.

Interventions

  • PROCEDURE Electromagnetic Navigation Bronchoscopy

Trial Details

FieldValue
Enrollment Target 1,388 participants
Start Date 2015-04-16
Est. Completion 2019-11-01

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT02410837

The ClinicalTrials.gov registry entry for NCT02410837 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,388 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Electromagnetic Navigation Bronchoscopy is the first listed.

NCT02410837 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02410837 about?

NCT02410837 is a clinical study titled "NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™". The purpose of this study is to evaluate outcomes following electromagnetic navigation bronchoscopy™ (ENB™) procedures using the superDimension™ navigation system.

What is the current status of trial NCT02410837?

This trial is currently completed. The enrollment target is 1,388 participants. The study started on 2015-04-16. Estimated completion is 2019-11-01.

What interventions are being tested in trial NCT02410837?

The interventions under investigation include: Electromagnetic Navigation Bronchoscopy (PROCEDURE).

Who is sponsoring clinical trial NCT02410837?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.